Latest Industry Insights

To learn about the progress being made in the RNA therapeutics space, we spoke to CTO and Co-Founder of La Jolla Labs, Jeff Milton, at the 2025 SLAS international meeting in San Diego.

UK Biocentre is adopting Azenta’s BioArc™ Ultra™, an automated -80°C storage system, to enhance biobanking efficiency and sustainability. With high-density storage and precise temperature control, it safeguards valuable samples.

Louise Digby, vice president of enzymes and bioproduction at BioProduction by SEKISUI, discusses some of the current challenges in scaling microbial fermentation for biopharmaceutical production and how a CDMO can help overcome these challenges.

A new collaborative trial is exploring how music and VR could provide a personalized anxiety treatment. Technology Networks spoke with the team behind the trial to learn more.

In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

Vivek Vishnudas discusses the unique advantages of E2-based TPD and its potential to revolutionize treatment for challenging diseases.

In this interview, we learn more about Nuclera's eProtein Discovery™ system, cutting protein production to 48 hours, solving solubility challenges and accelerating R&D with a "fail fast, succeed faster" strategy.

Cancer Research Horizons and Diamond Light Source aim to strengthen their partnership, combining their expertise and resources to bring new cancer treatments to patients.

Parag Mallick, Stanford scientist and Nautilus co-founder, is looking to transform proteomics with a platform for proteome-wide analysis, advancing diagnostics and disease research.

Levi Rogers reviews organizational-level support for lab sustainability, including developing organizational sustainability commitments, employee reward programs and cross-organizational partnerships.